Welltica+ on MSN
Diabetes medication may reduce risk of eye disease by 37 percent
A common medication may have an unexpected effect on a serious eye condition, new research suggests.
The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...
Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular degeneration.
Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.
In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...
Zacks Investment Research on MSN
ALDX crashes 71% as FDA issues third CRL for dry eye disease drug NDA
Shares of Aldeyra Therapeutics ALDX plunged 70.7% on Tuesday after the company announced receiving a Complete Response Letter ...
Please provide your email address to receive an email when new articles are posted on . Patients with inherited retinal diseases may present with seemingly routine conditions. Look for comorbid ...
With the number of diabetes cases surging across India, doctors warn that a silent epidemic of diabetes-related vision loss is emerging, particularly among younger adults. Lack of awareness, delayed ...
OCGN's gene-agnostic eye therapy aims to treat multiple retinal mutations, with key filings and pivotal data in 2026???2027 set to test its broad platform.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results